Phenotypic heterogeneity and the paucity of validated biomarkers in psoriatic disease (PsD) pose clinical assessment and management challenges. Peripheral arthritis, enthesitis, and dactylitis significantly increase the disease burden [1]. Early identification of these features and timely initiation of therapy obviates permanent deformities, thus improving the quality of life [2]. Conventional radiographs, although easily accessible and cost-effective, furnish information only regarding the irreversible structural changes that have already occurred in the joints or entheses. Musculoskeletal ultrasonography (MSUS) and magnetic resonance imaging (MRI) enables sensitive visualization of ongoing inflammation and structural lesions (Table 1). Nonetheless, operator dependency with MSUS, limitations with the resolution and time taken for scanning with MRI leave space for further development in this space. High-resolution, advanced imaging techniques and artificial intelligence, though still nascent, can potentially lead us closer to precision medicine [3]. We review the imaging modalities that can find utility in PsD within this context, focusing on recent advances and prospects.